Could a lower HIV drug dose work just as well?
NCT ID NCT02384967
First seen Apr 04, 2026 · Last updated May 22, 2026 · Updated 7 times
Summary
This study tested whether reducing the daily dose of the HIV drug darunavir from 800 mg to 400 mg could keep the virus suppressed in 100 adults who already had undetectable viral loads. Participants were on a stable regimen including darunavir and two other drugs. The goal was to see if the lower dose maintained viral suppression below 50 copies/mL at 48 weeks. This is a disease control study, not a cure, as lifelong medication is still needed.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV INFECTION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Hôpital Saint Louis
Paris, 75010, France
Conditions
Explore the condition pages connected to this study.